Amazon launches six-month $6 prescriptions to Prime members

The new benefit program follows Walmart's announcement and seeks to disrupt the prescription drug market.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Amazon (NASDAQ: AMZN) announced today that it is launching a new prescription program for members of its Prime loyalty program, less than a day after Walmart (NYSE: WMT) said it was offering Walmart+ members a discounted prescription service as well.

Having acquired PillPack in 2018, Amazon has been looking to leverage its ability to buy prescription medicine in bulk and provide savings to members in a bid to take a large slice of the $360 billion prescription drug market.

Like the Walmart program, Amazon's new service is looking for patients who take just a small number of fairly common medicines, such as those used to treat high blood pressure and diabetes; they'll pay as little as $1 per month and receive a six-month supply.

Six months is typically longer than what insurance companies will pay for, so consumers could see real savings by enrolling in the healthcare prescription program. As Prime members, they'd also be entitled to receive free two-day delivery.

The new offer is an expansion of the Amazon Pharmacy benefit announced last month that allows Prime members to comparison shop for savings through its network of 60,000 pharmacies. It noted Prime members save 80% on generic medications and 40% on name-brand ones through Amazon Pharmacy.

Walmart just introduced Walmart+ RX, which also provides significant discounts on commonly used medications. It notes that members of Walmart+, a loyalty program the retailer launched to challenge Amazon Prime, can get some common medications free while saving up to 85% on others.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Rich Duprey has no position in any of the stocks mentioned. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Amazon. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. The Motley Fool Australia has recommended Amazon. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on International Stock News

Three rockets heading to space
International Stock News

SpaceX shares under pressure despite revenue beat

Solid results have failed to lift the stock.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
International Stock News

What do Microsoft's strong earnings mean for these ASX shares?

Hyperscaler spending is the demand catalyst for these ASX shares.

Read more »

Three rockets heading to space
International Stock News

SpaceX shares continue to slide. What's the next catalyst for a recovery?

Analysts back the company, but investors seem lukewarm.

Read more »

A woman sits at her desk thinking. She is surrounded by projections of world maps on various screens with data appearing below them.
International Stock News

Why it's vital for investors to look to international shares for growth: Expert 

Are you at risk of home bias?

Read more »

A girl wearing a homemade rocket launches through the stars.
International Stock News

Analysts are still bullish on SpaceX shares after Nasdaq inclusion. Here is what that means for ASX investors

SpaceX joined the Nasdaq-100 and analysts are still bullish. Here is what that means for Australian investors who already own…

Read more »

Three rockets heading to space
International Stock News

How high will SpaceX shares go according to UBS?

The company could dominate major economic sectors, the broker says.

Read more »

Man with rocket wings which have flames coming out of them.
International Stock News

SpaceX shares continue to fall. Where will they end up?

Analysts are still bullish about the SpaceX share price.

Read more »

A player with tech goggles inside the metaverse.
International Stock News

Magnificent 8? Meet the US tech stock up 215% in 2026

A new tech stock is the latest member of the trillion-dollar club.

Read more »